Guardant Health
GH
#1787
Rank
ยฃ8.36 B
Marketcap
ยฃ63.80
Share price
-3.96%
Change (1 day)
91.35%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -ยฃ2.47

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -ยฃ2.50. In 2024 the company made an earnings per share (EPS) of -ยฃ2.68 an increase over its 2023 EPS that were of -ยฃ3.23.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ2.47-7.93%
2024-ยฃ2.68-16.82%
2023-ยฃ3.23-33.12%
2022-ยฃ4.8360%
2021-ยฃ3.0255.04%
2020-ยฃ1.95207.14%
2019-ยฃ0.63-19.81%
2018-ยฃ0.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-ยฃ2.09-16.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-ยฃ1.61-35.35%๐Ÿ‡บ๐Ÿ‡ธ USA